Connect with us

Research

Warmer temperatures might be slowing coronavirus transmission

Published

on

It is a known fact that warmer temperatures tend to reduce the transmission rates of majority of the viruses. Particularly, the ones related to respiratory issues, e.g. Influenza. A recent speculation suggests that the same is true for coronavirus.
 
In the past 8 months, coronavirus has spread to almost every country on the globe. Effecting more than half a million people and causing thousands of deaths, the virus is still actively spreading. Forcing nations into lockdown, the crisis has caused an economic crisis, along with a severe epidemic.
 
Based on the behavior of respiratory viruses, it is possible that warmer temperature might be affecting the coronavirus transmission. The impact can play a vital role in predicting if the following months would be better.

Research study

A research team from Mount Auburn Hospital, studied the effects of precipitation, temperature and UV index on the spread of the coronavirus. The analysis was primarily based on the death rate during the spring months.
A medical journal, Clinical Infectious Diseases, published the findings. Results indicated that the transmission rate of coronavirus did slow down up till 52 degrees Fahrenheit. However, increasing the temperature further had no impact on the virus.
 
Further, a greater UV index also reduced the average number of new cases per day. However, the impact was not that significant. Precipitation had no effect on the virus whatsoever.
 
The researchers evaluated regular reported instances of the coronavirus cases over the period of 2.5 months, from 22 January to 3 April. John Hopkins University’s Dashboard for coronavirus was the primary source for the data. Information about the environmental factors was taken from the National Centers for Environmental Information.

Results

Researchers analyzed the two datasets using advanced data science techniques. However, the results did not show any promise as to a possible slowing down of the disease. According to Shiv T. Sehra, Director Internal Medicine Residency Program at the hospital, it is unlikely that the coronavirus’s spread would slow down in the summers due to the increasing temperatures.
 
The study divided the data into five possible scenario categories: < 30 degrees, 30 – 40 degrees, 40 – 50 degrees, 50 – 60 degrees and > 60 degrees. All temperature measurements were in Fahrenheit. The team observed the maximum number of new cases on days when the temperature was below 30 degrees. Similarly, the least number of new cases were observed when the average temperature was above 50 degrees.
 
As per the Centers of Disease Control and Prevention, as fall and winter draw near, the crisis may get worse. The drop in temperatures will most likely cause a surge in the number of cases. Sehra stated, “We also caution that the disease may get worse in the fall and winter months.”

Limitations

Even though, the research did not show promising results, it is to note that there were a lot of limitations in the process. The study extrapolated the climate related data for the whole nation. Further, the data was from a time period when the overall temperatures were below 70 degrees. Temperature in summers is generally higher in most states.
 
Moreover, there is no guarantee that the number of cases depicted the correct value. Everyday, there are hundreds of cases that go unreported. Hence, adding a bias to the results. Geographical data was also ignored, which could potentially have a vital impact on the number of cases.
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

Study Reveals Vaping Cannabis Is More Lethal Than Smoking For Teenagers

mm

Published

on

Cannabis vaping

Everyone knows vaping damages the lungs of individuals. But a recent study suggests that vaping cannabis damages the lungs of teenagers more than vaping tobacco. The risk of lung injury increases in individuals between the ages of 12 to 17 years old if they have a habit of vaping cannabis.

The lung injury causes difficulty in breathing, whistling, and wheezing. Moreover, due to difficulty in breathing, teenagers become unable to perform day-to-day activities. According to the study, teenagers who vape cannabis have a doubled risk of developing lung injuries than teens who smoke or use e-cigarettes. 

Research Regarding Vaping Cannabis 

The research leader was Carol Boyd, and it occurs in collaboration with the University of Michigan. Carol Boyd is a professor at the university’s School of Nursing. Boyd is co-director of the University of Michigan’s Center for the Study of Drugs, Alcohol, Smoking, and Health.

According to Boyd, smoking cigarettes or e-cigarettes is unhealthy for health, but vaping cannabis is more damaging than both. 

ALSO READ: Cannabis Industry, Celiac Disease, And Processed Flour

The researchers did not note whether teens consumed legal cannabis or not. Thousands of participants between 12 to 17 ages were surveyed for the research study. Furthermore, the participants themselves reported symptoms of lung injury in the Population Assessment of Tobacco and Health Study. 

Moreover, the researchers discovered that cigarettes and e-cigarettes do not cause respiratory illness and injury. However, the research does not focus on the effect generated by vaping cannabis and tobacco together. 

Survey Findings

According to survey-based research, teenagers who vape cannabis have an 81% greater risk of wheezing or whistling in the chest. The increase in wheezing is observable in cigarette and e-cigarette users as they exhibit a 15% raise, and a 9% rise in the risk of wheezing, respectively. 

Apart from the increase in whistling teens, they also experience other changes due to vaping cannabis. Teenagers who are habitual of vaping marijuana suffer 71% sleep disturbances due to wheezing while sleeping. 96% speech limitations, 33% wheezing during exercise, and 26% dry coughing at night occur in teens that vape cannabis. The overall health condition of teenagers gets worse with vaping cannabis. Smoking and e-cigarettes also damage the lungs, but the effects of vaping marijuana are more severe.  

Moreover, the use of vaping devices has increased, and so have the mysterious lung illnesses. Furthermore, before the coronavirus pandemic, the deaths of individuals due to cannabis vaping increased. It results in the downfall of vaping industry. 

What Do Others Have To Say About Vaping Cannabis?

The Centers for Disease Control and Prevention noted that vitamin E acetate is present in all teenagers with a mysterious lung illness-causing respiratory symptoms. Moreover, vitamin E acetate is a constituent of the e-liquids containing THC, called EVALI. Thus, vaping marijuana is a cause of lung injury leading to wheezing during exercise and other symptoms of lung-illness. 

Furthermore, individuals that have lung injuries contain Vitamin E acetate in their pulmonary fluid. According to Boyd, vaping-associated lung injuries and vitamin E acetate have a link to one another.  

ALSO READ: U.S. States Most Likely To Legalize Cannabis Recreational Use

Michael R. Bloomberg is the founder and majority owner of Bloomberg News. Michael R. Bloomberg opposes vaping of cannabis and tobacco. Moreover, Bloomberg has organized campaigns and gives money for banning e-cigarettes and tobacco-vaping in the U.S. 

According to Dr. Albert Rizzo, the FDA does not ensure that cannabis products and e-cigarettes contain the ingredients mentioned on the label. Moreover, according to Rizzo, individuals and teens vaping cannabis and tobacco are at the mercy of the manufacturer.

Furthermore, Rizzo criticizes that the manufacturers of cigarettes, e-cigarettes, and vaping devices are not providing FDA sufficient data. They are not removing products from the market as per prior decisions. 

According to Rizzo, researchers must focus on the effects of inhaling substances and vaping devices on lung conditions. 

Continue Reading

Cannabis

Study Opens Gateway For Using Marijuana For Treatment Of PTSD

Published

on

Marijuana for PTSD

As the cannabis industry is evolving and generating large-profits, scientists and researchers are also focusing on discovering more about marijuana. Moreover, researchers aim to find better treatment possibilities, dose adjustments, and products that can help individuals. A recent study suggests marijuana can help treat PTSD, reports Forbes

However, the study is under process and has been approved by FDA, for phase 2 trials. Sue Sisley, MD, discussed her study goals and discoveries in a symposium for marijuana, internist, and telemedicine. Her study aims to use marijuana to treat people who suffer from PTSD disorder. 

Other researchers, research institutions, and companies are also working on similar projects. The Battle Brothers Foundation also gets approval for researching the use of cannabis to combat PTSD in veterans. Moreover, there is an urgent need to treat PTSD in veterans as the suicide rate due to post-traumatic stress disorder is getting higher. 

ALSO READ: Colorado In Need Of Regulations To Restrict Marijuana Concentrates To Keep Teens Safe

Sisley Cannabis Research For PTSD treatment

Sue Sisley was for many years an anti-marijuana. However, her perspective regarding cannabis changed when she was treating veterans. While she was treating them, she discovered that the veteran community uses higher doses of marijuana. Moreover, overdoses of the drug occur in them, and they start using addictive medications.

For her study, the University of Colorado gave $2.15 million in funds. Moreover, the study subject is one of a kind and will enable marijuana-use to treat PTSD. She was able to get approval for phase 2 trials after seven years of hard work. Sixty veterans were part of the research trials. They were given 12 percent THC and 12 percent CBD for treatment. 

Individuals show improvement in symptoms and overall condition. The study monitors biomarkers for inflammation, DSM-5, objective sleep measurement, and Inventory of Depression and Anxiety Symptoms. 

Battle Brothers Foundation Research 

The Battle Brothers Foundation is working with NiaMedic to determine marijuana use for treating PTSD. Furthermore, the national Independent Review Board is an independent committee that allows both groups to perform the research project. 

To determine the effects of marijuana on treating psychotic disorders, the researchers will enroll 60 California veterans. Individuals will also receive limited cannabis doses for treatment of post-traumatic stress disorder. 

According to Bryan Buckley, 22 veterans are dying due to the effects of post-traumatic stress. Moreover, they become addicted to opioids. 

Cases of post-traumatic stress disorder in U.S. troops have increased remarkably in the last 13 years. It is the need of the hour to research and formulate better techniques for improving the condition of individuals suffering from PTSD. 

Moreover, the veterans that have been offering services in Afghanistan and Iraq suffer from a psychotic disorder. Data analysis will occur in the presence of medical doctors and experts. 

ALSO READ: U.S. States Most Likely To Legalize Cannabis Recreational Use

Marijuana Use And PTSD

Individuals have been given cannabis edible products for medical use. The controlled drug is psychoactive that elevates mood, makes individuals relax, and generates a feeling of pleasure. 

Individuals that have been through immense trauma, stress, and pain are more likely to develop post-traumatic stress disorder. Moreover, individuals that experience or witness any natural disaster, an accident, a terrorist’s act, war or rape, death threats, and sexual violence are likely to suffer PTSD. Marijuana can provide a solution to the problem and symptoms of post-traumatic stress disorder. 

The research subject will open a new field for use of cannabis and improves the condition of marijuana. However, completion of research requires some time, and to obtain large-scale research results research on a wider scale needs to occur. 

The efforts of Sue and the Battle Brothers Foundation will yield a positive outcome separately. Moreover, it will provide hope to individuals suffering from post-traumatic-stress-disorder. 

Continue Reading

Cannabis

Cannabis Antibiotics Can Be Solution For Treating Drug-Resistant Diseases 

Published

on

Cannabis Antibiotics

The cannabis plant contains multiple components of varying benefits, of which some constituents are psychoactive while others are non-psychoactive and have other pharmacological impacts. Because of the pharmacological benefits, researchers are working to formulate cannabis antibiotics.  

According to the research of The University of Queensland, CBD is a component present in marijuana, is non-psychoactive, and is capable of killing bacteria. It is useable in antibiotics due to its ability to kill bacteria responsible for gonorrhea, meningitis, and legionnaires. 

Moreover, according to studies, there is a possibility that drug-resistance diseases can cause more than 10 million deaths per year by 2050. The UN warns that there is an urgent need to deal with drug-resistant illnesses. Furthermore, finding solutions to the problems of drug resistance must be of utmost priority. 

ALSO READ: The Life of Marijuana Patients Made Easy By Advanced Technology

Drug resistance is growing, leading to critical problems shortly. According to neurologists, within five years, the NHS will successfully develop effective cannabis-antibiotics. Moreover, the treatment of drug-resistant diseases will be possible with the use of this marijuana containing antibiotics. 

Cannabis In Antibiotics

CBD is the cannabidiol, a major non-psychoactive and second-most prevalent component of the active ingredients of marijuana. Two institutions researched using cannabis in antibiotics. The institutions that collaborate for research are the University of Queensland and Botanix Pharmaceuticals Limited

In their research, researchers examined how the CBD of cannabis penetrates through the protective membranes of multiple bacteria. Moreover, not only does the CBD enter the bacteria, but it also kills them. 

Of the bacteria through which CBD penetrates are bacteria for meningitis, legionella, and Neisseria gonorrhea. The legionella bacteria cause legionnaire’s disease characterized by cough, shortness of breath, high fever, muscle pain, nausea, vomiting, and headache.

The researchers found that CBD was able to break down the biofilm of the bacteria. Biofilm is a slimy build-up of bacteria released by it to survive against antibiotic treatment. Moreover, the biofilm’s slimy layer is similar to a dental plaque on the surface.

What Is In The Future For Cannabis?

Cannabis-infused antibiotics may be available in the market. According to Professor Mike Barnes, pretty-soon general practitioners will start prescribing CBD pills to treat infectious diseases. Research on marijuana is progressing fast. Moreover, there are chances of formulating much better cannabis products for medicinal use. 

According to Mike Barnes, it is high time that individuals understand the medical benefits of marijuana and take advantage of the plant to its full capacity. Moreover, the marijuana plant is useable in various ways to improve the condition of patients. 

The new research led by the University of Queensland and Botanix Pharmaceutical Limited is helpful in the subject. However, further research is vital for developing much better, safer, and effective drugs containing CBD of marijuana.

More Studies Essential For A Better Future

According to Professor Mike Barnes, if CBD is placed next to bacteria in a plate, the cannabidiol will kill the bacteria right away. However, if a tablet containing CBD is on the same plate as the bacteria, the effect of CBD will be slower. 

ALSO READ: International Market For Marijuana-Infused Drinks On The Rise

The professor is confident that with further research on the subject, better medicine formulation can occur for treating drug-resistant diseases. Moreover, UK regulators can formulate something that can fight against antibiotic-resistant gonorrhea. Furthermore, the formation of antibiotics for drug-resistant gonorrhea is the utmost priority of the World Health Organization. 

Once the formulation of the cannabis-containing antibiotics is complete, the drugs will need the approval to conduct preclinical-trials and clinical trials. After completing the clinical trials and research investigations, the authorities will consider the drugs for approval after which they will be available in the market. 

Deep studies and research investigations enable the formulation of a more effective formulation. The quicker the cannabis containing antibiotics gets approval, the sooner they will be in the market for treating drug-resistant bacterial diseases. 

 

Continue Reading

Trending

error: Content is protected !!